TARGETING TRANSCRIPTIONAL ADDICTION FOR GBM THERAPY THROUGH CDK7 INHIBITION

被引：0

作者：

Meng, Wei ^{[1
]}

Wang, Jiajia ^{[1
]}

Li, Qifeng ^{[1
]}

Liu, Fang ^{[2
]}

Li, Meng ^{[2
]}

Jiang, Wenyan ^{[2
]}

Lin, Li ^{[3
]}

Dai, Xiaomin ^{[3
,4
]}

Wang, Hongxiang ^{[5
]}

Zhang, Chenran ^{[1
]}

Wang, Baocheng ^{[1
]}

Chen, Juxiang ^{[5
]}

Zhang, Liye ^{[3
]}

Tang, Yujie ^{[1
,2
]}

Ma, Jie ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurosurg, Shanghai, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Natl Minist Educ,Dept Pathophysiol, Shanghai, Peoples R China

[3] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China

[4] Univ Chinese Acad Sci, Beijing, Peoples R China

[5] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TBIO-01

引用

页码：180 / 180

页数：1

共 50 条

[31] CDK7/CDK9 mediates transcriptional regulation to prime cancer cell paraptosis
Chang, Ling-Chu
Chiang, Shih-Kai
Chen, Shuen-Ei
CANCER RESEARCH, 2024, 84 (06)
[32] CDK7/CDK9 mediates transcriptional activation to prime paraptosis in cancer cells
Chiang, Shih-Kai
Chang, Wei-Chao
Chen, Shuen-Ei
Chang, Ling-Chu
CELL AND BIOSCIENCE, 2024, 14 (01):
[33] Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma
Cao, Xinyi
Dang, Lin
Zheng, Xiangqian
Lu, Yi
Lu, Yumei
Ji, Rongjie
Zhang, Tianye
Ruan, Xianhui
Zhi, Jingtai
Hou, Xiukun
Yi, Xianfu
Li, Mulin Jun
Gu, Tingyu
Gao, Ming
Zhang, Lirong
Chen, Yupeng
THYROID, 2019, 29 (06) : 809 - 823
[34] CDK7 inhibition suppresses MYC-dependent cancer
Sarah Crunkhorn
Nature Reviews Drug Discovery, 2015, 14 (1) : 16 - 16
[35] Potent and selective inhibition of CDK7 by novel covalent inhibitors
Satyam, L.
Poddutoori, R.
Mukherjee, S.
Marappan, S.
Gopinath, S.
Pothuganti, M.
Nayak, S.
Kaza, L.
Nandish, C.
Amith, A.
Ravindra, M.
Nagaraju, A.
Antony, T.
Pandit, C.
Chelur, S.
Daginakatte, G.
Samajdar, S.
Ramachandra, M.
EUROPEAN JOURNAL OF CANCER, 2016, 69 : S127 - S127
[36] Selective inhibition of CDK7 ameliorates experimental arthritis in mice
Xia, Yong
Lin, Li-Ying
Liu, Mei-Ling
Wang, Zheng
Hong, Hong-Hai
Guo, Xu-Guang
Gao, Guo-Quan
CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 15 (03) : 269 - 275
[37] Potent and selective inhibition of CDK7 by novel covalent inhibitors
Satyam, Leena Khare
Poddutoori, Ramulu
Mukherjee, Subhendu
Marappan, Sivapriya
Gopinath, Sreevalsam
Ramachandra, Raghuveer
Pothuganti, Manoj Kumar
Nayak, Shilpa S.
Nandish, C.
Naik, Chandranath
Ravindra, M., V
Dabbeeru, Madhu B.
Nagaraju, A.
Mahankali, B.
Antony, Thomas
Pandit, Chetan
Chelur, Shekar
Daginakatte, Girish
Sannajdar, Susanta
Ramachandra, Murali
CANCER RESEARCH, 2016, 76
[38] Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Sun, Bowen
Mason, Seth
Wilson, Robert C.
Hazard, Starr E.
Wang, Yubao
Fang, Rong
Wang, Qiwei
Yeh, Elizabeth S.
Yang, Meixiang
Roberts, Thomas M.
Zhao, Jean J.
Wang, Qi
ONCOGENE, 2020, 39 (01) : 50 - 63
[39] Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma
Li, Xiaoyang
Dean, Dylan C.
Yuan, Jin
Temple, Thomas H.
Trent, Jonathan C.
Andrew, E. Rosenberg
Shengji, Yu
Francis, J. Hornicek
Duan, Zhenfeng
BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
[40] Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
Chen, Hua-Dong
Huang, Chen-Song
Xu, Qiong-Cong
Li, Fuxi
Huang, Xi-Tai
Wang, Jie-Qin
Li, Shi-Jin
Zhao, Wei
Yin, Xiao-Yu
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (07): : 1207 - 1217

← 1 2 3 4 5 →